Back to Search
Start Over
Data presented on antitumor effects of immunomodulatory oligonucleotides
- Source :
- Drug Week. March 28, 2003, 29
- Publication Year :
- 2003
-
Abstract
- 2003 MAR 28 - (NewsRx.com & NewsRx.net) -- Hybridon, Inc., (HYBN.OB) announced the presentation of preclinical studies of its immunomodulatory oligonucleotides (IMO) at the American Association for Cancer Research (AACR) [...]
- Subjects :
- Hybridon Inc.
Biotechnology industry
Pharmaceuticals and cosmetics industries
Subjects
Details
- Language :
- English
- ISSN :
- 15316440
- Database :
- Gale General OneFile
- Journal :
- Drug Week
- Publication Type :
- News
- Accession number :
- edsgcl.99045809